Note: Links to these online articles may no longer be active. They are provided here as a reference only. They may continue to be available via the host site's archive.
Mike Toth and the Art of Branding
Feb. 5, 2014 (Boston Globe) – This article introduces Mike Toth, a branding guru, and mentions his collaboration with his doctor, Director of the Division of Head and Neck Surgical Oncology and Director of the Norman Knight Center, Dr. Daniel Deschler. On Sunday, Feb. 9., Toth and Dr. Deschler will come together for the opening of Toth’s photography exhibit. Proceeds of the exhibit will go towards funding Dr. Deschler’s work. More on the exhibit can be seen here.
Potential Therapeutic Role for Aspirin in the Management of Sporadic Vestibular Schwannoma
Feb. 5, 2014 (ASCO Post) – In patients with sporadic vestibular schwannoma, aspirin may be of benefit in minimizing tumor growth, according to new results presented in the journal of Otology and Neurotology. This finding may eliminate the need for invasive therapy and may complement existing modalities. Lead Author Konstantina Stankovic, M.D., Ph.D., of Mass. Eye and Ear, remarked, “Currently, there are no FDA-approved drug therapies to treat these tumors, which are the most common tumors of the cerebellopontine angle and the fourth most common intracranial tumors. Our results suggest a potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth.”
Aspirin Could Slow Noncancerous Brain Tumors
Feb. 3, 2014 (Health 24) – A study funded in part by the National Institute on Deafness and Other Communication Disorders and conducted by researchers on over 700 patients shows that aspirin might slow the growth of a noncancerous type of brain trumor that can lead to hearing loss, tinnitus, or ringing in the ears, or even death. "Our results suggest a potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth," said Study Leader Dr. Konstantina Stankovic, otologic surgeon and researcher at Mass. Eye and Ear.
Aspirin Might Help Treat Brain Tumor Tied to Hearing Loss
Jan. 30, 2014 (Health Day) – A new study on the effects that aspirin can have on vestibular schwannomas and tinnitus, or ringing in the ears, revealed that the rate of tumor growth was slower in patients who took aspirin than in those who didn't take the drug. Age and gender did not affect the findings."Our results suggest a potential therapeutic role of aspirin in inhibiting vestibular schwannoma growth," said Study Leader Dr. Konstantina Stankovic, otologic surgeon and researcher at the Mass. Eye and Ear.
Postmenopausal Estrogen Therapy Tied to Lower Glaucoma Risk
Jan. 30, 2014 (Health Day News) – New research has shown that women who take estrogen-only hormone-replacement therapy to relieve menopausal symptoms might also be reducing their risk for glaucoma. However, Dr. Angel Turalba, glaucoma specialist at Mass. Eye and Ear, has said, “The new study results do not suggest that reducing risk of glaucoma is reason enough to take hormone replacement therapy.” This kind of therapy can increase health risks, like heart disease, breast cancer and stroke.
Children Born Blind Can Learn to See as Teenagers
Jan. 29, 2014 (Nature) – In a study of children born with blindness who underwent surgery to restore vision, researchers have found that the brain can still restore vision later in life. Researchers tested the children's ability to perceive contrast between varying shades of grey, a skill that would make it possible to read many texts, for example. The study was carried out using software developed by co-author Luis Andres Lesmes and a team led by Vision Scientist Peter Bex, Ph.D., at Harvard Medical School . The test was administered two times following surgery, six months apart. Of the 11 children studies, five of the patients showed progression in their vision.
Visual System Can Retain Considerable Plasticity After Extended Blindness
Jan. 27, 2014 (Medical Xpress) – A new study conducted by researchers at Mass. Eye and Ear, Harvard Medical School and Mass. Institute of Technology shows that the human visual system can retain plasticity beyond critical periods, even after early and extended vision loss during childhood. "Our research group has been studying the development of vision in children who were blind from birth because of congenital cataracts. We have been measuring if and how their vision develops after surgery in late childhood and adolescence to remove cataracts, which enable sight for the first time. Our results show remarkable plasticity and vision continues to improve in many children long after the surgery," said Senior Author Dr. Peter J. Bex.
Study Suggests Potential Therapeutic Role of Aspirin in Inhibiting Vestibular Schwannoma Growth
Jan. 24, 2014 (News Medical) – Researchers from Mass. Eye and Ear, Harvard Medical School, Mass. Institute of Technology and Mass. General Hospital have demonstrated, for the first time ever, that aspirin intake relates directly to halted growth of vestibular schwannomas, or acoustic neuromas. This is a potentially lethal intracranial tumor that can cause hearing loss and tinnitus. "Currently, there are no FDA-approved drug therapies to treat these tumors, which are the most common tumors of the cerebellopontine angle and the fourth most common intracranial tumors," explains Konstantina Stankovic, M.D., Ph.D., Mass. Eye and Ear clinican-researcher and assistant professor of otology and laryngology at Harvard Medical School, who led the study. "Current options for management of growing vestibular schwannomas include surgery, via craniotomy, or radiation therapy, both of which are associated with potentially serious complications.'"
No More Eye Drops? Contact Lens Prototype Delivers
Jan. 22, 2014 (Live Science) – Researchers at Mass. Eye and Ear and Harvard Medical School have developed a contact lens that directly delivers treatment to the eye for patients with glaucoma. The medication can also help correct vision in such patients. People using traditional eye drops for glaucoma "aren't getting any symptomatic relief, and they're not seeing better, so there's not a lot of motivation to be compliant with the medication," said Dr. Joseph Ciolino, the ophthalmologist who, along with his mentor Dr. Daniel Kohane, developed the new contact lens at Harvard Medical School.
New Tool to Predict Retinal Detachment after OGI
Jan. 10, 2014 (Optometry UK) – Looking at data from over 893 patients diagnosed with an open globe injury between 1999 to 2011, a team from Mass. Eye and Ear found that 29% of the patients went on to develop retinal detachment.Dr. Dean Elliot, lead author if the study and associate director of the Retina Service at Mass. Eye and Ear, has said: “The RD-OGI score may be useful to help the ophthalmologist predict which patients are at a higher risk for retinal detachment after open globe trauma.”
Open Globe Trauma May Lead to Retinal Detachment
Jan. 7, 2014 (Healio) – In a retrospective study of over 893 patients with open globe injury at Mass. Eye and Ear for the past 10 years, investigators measured detachment time and clinical factors of retinal detachment after open globe injury using a tool called multivariable logistic regression. Open globe trauma commonly causes retinal detachment, which may take weeks to appear after the traumatic event, according to the study.
New Tool May Help Predict Retinal Detachment After Open Globe Injuries
Jan. 2, 2014 (News Medical) – Researchers from Mass. Eye and Ear, Harvard Vanguard Medical Associates and Harvard Medical School’s Department of Ophthalmology report on the first study in 35 years that reviews the circumstances around retinal detachment after open globe injuries (OGI) and describes a new tool that may help ophthalmologists predict which patients are at higher risk after open globe trauma so they can potentially prevent retinal detachment from happening or identify, and help restore vision more quickly.
Insight Into Likelihood of Retinal Detachment Following Open Globe Injury
Jan. 1, 2014 (Medical Xpress) – Ocular trauma causing a breach in the wall of the eye, or open globe injury (OGI), is a major cause of vision loss, with more than 200,000 open globe injuries occurring worldwide each year. Retinal detachment can follow this injury, causing significant vision loss of blindness. Researchers at Mass. Eye and Ear performed a retrospective review of about 1,036 consecutive OGIs evaluated by the Eye Trauma Service of Mass. Eye and Ear from Feb. 1, 1999 to Nov. 30, 2011. “We took this information, along with other variables, and created the Retinal Detachment after Open Globe Injury (RD-OGI) score,” said Dr. Dean Elliot, a senior author and associate director of the Mass. Eye and Ear Retina Service. Dr. Stelios Evangelos Gragoudas, associate professor of ophthalmology at Harvard Medical School, said, “After prospective validation with independent cohorts, the RD-OGI score may be useful to help the ophthalmologist predict which patients are at higher risk for retinal detachment after open globe trauma."